HZNP - Horizon Pharma Plc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - HZNP (1492426)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
6 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P1+7+0+0+0
S1+0-7-7+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2018-08-16
HZNPCurtis Geoffrey M.EVP, Corporate Affairs, CCOS - Sale$20.63-9,90429,187-25%-$204,361
2018-06-08
HZNPBeeler Brian KEVP, GCS - Sale$17.58-15,43379,530-16%-$271,249
D
2018-06-01
HZNPWalbert Timothy PCOB, Pres, CEOS - Sale+OE$16.17-83,353546,070-13%-$1,348,218
D
2018-05-25
HZNPBeeler Brian KEVP, GCS - Sale+OE$16.11-17,93192,593-16%-$288,868
2017-05-10
HZNPGrey Michael GDirP - Purchase$9.48+10,00025,448+65%+$94,800+7
DM
2017-02-28
HZNPCarey RobertEVP, Chief Business OfficerS - Sale+OE$16.03-31,80896,008-25%-$509,7960-7-7
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top